New Delhi, Sept. 6 -- The recent decision by the Government to reduce the Goods and Services Tax (GST) on medicines from 12% to 5%, effective from September 22, 2025, has triggered significant financial concerns among pharmacies selling medicines across Delhi.
The Retail Distribution Chemist Alliance, Delhi, representing small and neighbourhood pharmacies, has expressed alarm over the immediate impact of the GST rate revision. Pharmacies claim they are grappling with the burden of accumulated GST input credits and unsold stock procured at the previous higher tax rate, resulting in considerable financial strain.
In a memorandum submitted to Delhi Chief Minister and Finance Minister Rekha Gupta, the RDCA, Delhi appealed for a transitional a...